Obstetrics & gynecology science

Korean Society of Obstetrics and Gynecology (대한산부인과학회)
권호 표지

Current concept of infertility treatment

불임치료의 최신지견

Lee, Woo-Sik
이우식

  • Published : 20050500
⟨ Previous Next ⟩

Abstract

Infertility is a disease that exists when a couple has tried to conceive for 12 months during which time they have had intercourse without the use of contraception. There are many factors suggested as causative factors for this problem and various diagnostic and therapeutic approaches are practicing to alleviate this infertility with great advancement in molecular biology, cryobiology and ART etc. During provision of infertility service, most importantly clinician keep in mind that comprehensive care should be individualized based on the couple’s situation. Even though there is advancement in this field, still there are remaining area to be explored and approaches yet to be developed for the future.

Keywords

References

  1. ASRM practice committee and ethics committee. Fertil Steril 2004; 82: sup. S206 https://doi.org/10.1016/j.fertnstert.2004.05.055
  2. 한국보건사회연구원. 우리나라 불임 및 불임관련 의료이용실태와 문제해결을 위한 연구 2003. 1
  3. Brugo-Olmedo S, Chillik C, Kopelman S, Definition and causes of infertility. RBM Online 2000; 2(1): 41-53
  4. Reproductive Endocrinology, Elsevier Saunders. 5th edition. P(636)
  5. W.D. Mosher and W.F. Pratt, Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991; 56: 192-3 https://doi.org/10.1016/S0015-0282(16)54469-0
  6. A.A. Luciano, J. Peluso, E.I. Koch, D. Maier, S. Kuslis and E. Davison, Temporal relationship and reliability of clinical, hormonal, and ultrasonographic indices of ovulation in infertile women. Obstet Gynecol 1990; 75: 412-6
  7. J. Jordan, K. Craig, D.K. Clifton and M.R. Soules, Luteal phase defect: the sensitivity and specificity of iagnostic methods in common clinical use. Fertil Steril 1994; 62: 54-627 https://doi.org/10.1016/S0015-0282(16)56815-0
  8. A.J. Wilcox, C.R. Weinberg and D.D. Baird, Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995; 333: 1517-21 https://doi.org/10.1056/NEJM199512073332301
  9. D. Shoupe, D.R. Mishell, Jr, M. Lacarra, R.A. Lobo, J. Horenstein, G. d'Ablaing, et al. Correlation of endometrial maturation with four methods of estimating day of ovulation. Obstet Gynecol 1989; 73: 88-92
  10. T.C. Li, P. Dockery, A.W. Rogers and I.D. Cooke, How precise is histologic dating of endometrium using the standard dating criteria?. Fertil Steril 1989; 51: 759-63 https://doi.org/10.1016/S0015-0282(16)60662-3
  11. L.C. de Crespigny, C. O'Herlihy and H.P. Robinson, Ultrasounic observation of the mechanism of human ovulation. Am J Obstet Gynecol 1981; 139: 636-9 https://doi.org/10.1016/0002-9378(81)90476-2
  12. F.I. Sharara, R.T. Scott, Jr and D.B. Seifer, The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998; 179: 804-12 https://doi.org/10.1016/S0002-9378(98)70087-0
  13. P. Schwarzler, H. Concin, H. Bosch, A. Berlinger, K. Wohlgenannt, W.P. Collins, et al. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound Obstet Gynecol 1998; 11: 337-42 https://doi.org/10.1046/j.1469-0705.1998.11050337.x
  14. B. Salle, P. Gaucherand, P. deSaintHilaire and R.C. Rudigoz, Transvaginal sonohysterographic evaluation of intrauterine adhesions. J Clin Ultrasound 1999; 27: 131-4 https://doi.org/10.1002/(SICI)1097-0096(199903/04)27:3<131::AID-JCU5>3.0.CO;2-3
  15. R.F. Valle, Tubal cannulation. Obstet Gynecol Clin North Am 1995; 22: 51-9540
  16. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidem 1994; 5: 247-50 https://doi.org/10.1097/00001648-199403000-00016
  17. Barbieri RL. The initial fertility consultation: recommendations concerning cigarette smoking, body mass index, and alcohol and caffeine consumption. Am J Obstet Gynecol 2001; 185: 1168-73 https://doi.org/10.1067/mob.2001.117667
  18. Zaadstra BM, Seidell JC, VanNoord PA, et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. Brit Med J 1993; 306: 484-7 https://doi.org/10.1136/bmj.306.6876.484
  19. Fedorcsak P, Storeng R, Dale PO, et al. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000; 79: 43-8 https://doi.org/10.1034/j.1600-0412.2000.079001043.x
  20. Barbieri RL, Hornstein MD. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect. Endo Met Clinics Nor Am 1988; 17: 685- 703
  21. Letiexhe MR, Scheen AJ, Gerard PL, et al. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clinic Endo Met 1995; 80: 364-9 https://doi.org/10.1210/jc.80.2.364
  22. Pasquali R, Casimirri F, Vicennati V, et al. Weight control and its beneficial affect on fertility in women with obesity and polycyatic ovary syndrome. Hum Reprod 1997; 12: 82-7 https://doi.org/10.1093/humrep/12.suppl_1.82
  23. Morin-Papunen LC, Koivunen RM, Tomas C, et al. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome. J Clinic Endo Met 1998a; 83: 2566-8 https://doi.org/10.1210/jc.83.7.2566
  24. Inmani B, Eijemans MJ,te Velde ER, et al. Predictors of patients remaining anovulatory duringclomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Cli Endo Metab 1998; 83: 2361-5 https://doi.org/10.1210/jc.83.7.2361
  25. Filicori M, Flamigni C, Dellai P, et al. Treatment of anovulation with pulastile goandotropin-Endo Metab 1994; 79: 1215-20 https://doi.org/10.1210/jc.79.4.1215
  26. Perotti L, Bianchi MM, colombo M, et al. In vitro fertilization: Poor ovarian response to human gonadotropins in overweight patients and in women over 35 years of age. Human Reproduction 1999; 14: 56
  27. Franks S. Polycyatic ovary syndrome. N Eng J Med 1995; 333: 853- 61 https://doi.org/10.1056/NEJM199509283331307
  28. Clark AM, Roberts B, Galletley C, et al. Maximizing weight loss in the overweight infertile patient- a prospective randomized controlled trial. Hum Reprod 2000; 15: 65-6 https://doi.org/10.1093/humrep/15.suppl_4.65
  29. Crosignani PG, Vegetti W, Colombo M, Ragni G. Resumption of fertility with diet in overweight women. RBM Online 2002; 5: 60-4
  30. Mikkelson TJ, Kroboth PD, Cameron WJ, Dittert LW, Chungi V, Mangerg PJ. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 1986; 46: 392-6 https://doi.org/10.1016/S0015-0282(16)49574-9
  31. Clark JH, Markaverich BM. The agonistic-antagonistic properties of clomiphene: a review. Pharmacol Ther 1982; 15: 467-519 https://doi.org/10.1016/0163-7258(81)90055-3
  32. Van Campenhout J, Borreman E, Wyman H, Antaki A. Induction of ovulation with cisclomiphene. Am J Obstet Gynecol 1973; 115: 321-7 https://doi.org/10.1016/0002-9378(73)90585-1
  33. Kerin JF, Liu JH, Phillipou G, Yen SS. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985; 61: 265-8 https://doi.org/10.1210/jcem-61-2-265
  34. Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamicpituitary- Fertil Steril 1993; 59: 532-8 https://doi.org/10.1016/S0015-0282(16)55795-1
  35. Rostami-Hodjegan A, Lennard MS, Tucker GT, Ledger WL. Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertil Steril 2004; 81: 1187-93 https://doi.org/10.1016/j.fertnstert.2003.07.044
  36. Quagliarello J, Weiss G. Clomiphene citrate in the management of infertility associated with shortened luteal phases. Fertil Steril 1979; 31: 373-7 https://doi.org/10.1016/S0015-0282(16)43930-0
  37. Guzick DS, Zeleznik A. Efficacy of clomiphene citrate in the treatment of luteal phase deficiency: quantity versus quality of preovulatory follicles. Fertil Steril 1990; 54: 206-10 https://doi.org/10.1016/S0015-0282(16)53690-5
  38. Fisch P, Casper RF, Brown SE, WrixonW, Collins JA, Reid RL, et al. Unexplained infertility: evaluation of treatment with clomiphene citrate and human chorionic gonadotropin. Fertil Steril 1989; 51: 828-33 https://doi.org/10.1016/S0015-0282(16)60674-X
  39. Deaton JL, Gibson M, Blackmer K, Nakajima ST, Badger GJ, Brumsted JR. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990; 54: 1083-8 https://doi.org/10.1016/S0015-0282(16)54009-6
  40. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril 1998; 70: 207-13 https://doi.org/10.1016/S0015-0282(98)00177-0
  41. Wu CH, Winkel CA. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989; 52: 564-8 https://doi.org/10.1016/S0015-0282(16)60964-0
  42. Dodge ST, Strickler RC, Keller DW. Ovulation induction with low doses of clomiphene citrate. Obstet Gynecol 1986; 67: 63S-65S https://doi.org/10.1097/00006250-198603001-00019
  43. Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade's experience with an individualized clomiphene treatment regime including its effect on the postcoital test. Fertil Steril 1982; 37: 161-7 https://doi.org/10.1016/S0015-0282(16)46033-4
  44. Azziz R. PCOS: A diagnostic challenge RBM online 2004; 8(6): 644-8
  45. Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-80 https://doi.org/10.1056/NEJM199806253382603
  46. Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steil 2003; 79: 1-13 https://doi.org/10.1016/S0015-0282(02)04554-5
  47. Kumari AS. Metformin monotherapy in lean women with polycystic ovary syndrome. RBM Online 2005; 10: 100-4
  48. Heard MJ, Pierce, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77: 669-73 https://doi.org/10.1016/S0015-0282(01)03266-6
  49. Nestler JE, Jakubowics DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomipheneand clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-80 https://doi.org/10.1056/NEJM199806253382603
  50. Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997; 90: 392-5 https://doi.org/10.1016/S0029-7844(97)00296-2
  51. Kim LH, Taylor AE, Barbieri RL. Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility Fertil Steril 2000; 73: 1097-8 https://doi.org/10.1016/S0015-0282(00)00540-9
  52. Opsahl MS, Robins ED, O'Connor DM, Scott RT, Fritz MA. Characteristics and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996; 66: 533-9 https://doi.org/10.1016/S0015-0282(16)58564-1
  53. Daly DC, Walters CA, Soto-Albors CE, Tohan N, Riddick DH. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984; 41: 844-8 https://doi.org/10.1016/S0015-0282(16)47896-9
  54. Isaacs JD Jr, Lincoln SR, Cowan BD. Extended clomiphene citrate(CC) and prednisone for the treatment of chronic anovulation resistant to CC alone. Fertil Steril 1997; 67: 641-3 https://doi.org/10.1016/S0015-0282(97)81359-3
  55. Schenker JG, Jarkoni S, Granat M. Multiple pregnancies following induction of ovulation. Fertil Steil 1981; 35: 105-23 https://doi.org/10.1016/S0015-0282(16)45308-2
  56. Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamicpituitary- ovarian response to clomiphene citrate in women polycystic ovarian syndrome. Fertil Steril 1993; 59: 532-8 https://doi.org/10.1016/S0015-0282(16)55795-1
  57. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth.Hum Reprod 1990; 5: 670-4 https://doi.org/10.1093/oxfordjournals.humrep.a137165
  58. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrialthickness and pattern to fecundity inovulation induction cycles; effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 1993; 59: 756-60 https://doi.org/10.1016/S0015-0282(16)55855-5
  59. Opshal MS, Robins ED, O'conner DM, Scott RT, Fritz MA. Characteristics of gonadotropin response, follicular development, and endometrial growth and, maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996; 66: 533-9 https://doi.org/10.1016/S0015-0282(16)58564-1
  60. MF, Casper RF. Aromatse inhibition improves ovarian response to follicle-stimulating hormone inpoor responders, Fertil Steril 2003; 77: 776-80
  61. Budzar AU, Robertson JF, Eiermann W, Nabholtz JM. An overview of pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole and exenmestrane. Cancer 2003; 95: 2006-16
  62. Mitwally MF, Casper RF. Single-dose administrationof an aromatase inhibitor for ovarian. stimulation. Fertil Steril 2005; 83: 229-31 https://doi.org/10.1016/j.fertnstert.2004.07.952
  63. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82: 1561-3 https://doi.org/10.1016/j.fertnstert.2004.04.070
  64. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192: 381-6 https://doi.org/10.1016/j.ajog.2004.08.013
  65. Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M, Hormonal profileand endometrial morphology in letrozolecontrolled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 2005; 83: 110-5 https://doi.org/10.1016/j.fertnstert.2004.05.099
  66. Dodson WC, Whitesides DB, Hughes CL JR, Easley HA Erd, Haney AF. Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. Fertil Steril 1987; 48: 441-5 https://doi.org/10.1016/S0015-0282(16)59414-X
  67. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk JR, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril 1998; 70: 207-13 https://doi.org/10.1016/S0015-0282(98)00177-0
  68. Kirby CA, Flaherty SP, Godfrey BM, Warnes GM, Matthews CD. A prospective trial of intrauterine insemination of motile spermatozoa versus timed intercourse. Fertil Steril 1991; 56: 102-7 https://doi.org/10.1016/S0015-0282(16)54426-4
  69. Arici A, Byrd W, Bradshaw K, Kutteh WH, Marshburn P, Carr BR. Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertil Steril 1994; 61: 314-8 https://doi.org/10.1016/S0015-0282(16)56524-8
  70. Welner S, DeCherney AH, Polan ML. Human menopausal gonadotropins: a justifiable therapy in ovulatory women with long- standing idiopathic infertility. Am J Obstet Gynecol 1988; 158: 111-7 https://doi.org/10.1016/0002-9378(88)90789-2
  71. Aboulghar MA, Mansour RT, Serour GI, Amin Y, Abbas AM, Salah IM. Ovarian superstimulation and intrauterine insemination for the treatment of unexplained infertility. Fertil Steril 1993; 60: 303-6 https://doi.org/10.1016/S0015-0282(16)56102-0
  72. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med 1999: 304: 177-83
  73. Balasch J. Gonadotropin ovarian stimulation and intrauterine insemination for unexplained infertility. RBM Online 2004; 9(6): 664- 72
  74. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilizationin idiopathic subfertility and male subfertility: a randomized trial and cost-effectiveness analysis. Lancet 2000; 355: 13-8 https://doi.org/10.1016/S0140-6736(99)04002-7
  75. Aboulghar MA, Mansour RT, Serour GI, et al. Management of long standing unexplained infertility: prospective study. Am J Obstet Gynecol 1999; 181: 371-5 https://doi.org/10.1016/S0002-9378(99)70564-8
  76. Omland AK, Abyholm T, Fedorcsak P, Ertzeid G, Oldereid NB, Bjercke S, Tanbo T. Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility. Hum Reprod 2005 Mar 20(3): 722-7 https://doi.org/10.1093/humrep/deh664
  77. Tarlatzis B, Grimbizis G. Future use of clomiphene in ovarian stimulation. Will clomiphene persist in the 21st century. Hum Reprod 1998; 13: 2356-8 https://doi.org/10.1093/humrep/13.9.2356
  78. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Eng J Med 1993; 331: 771-6
  79. Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 1982; 306: 404-6 https://doi.org/10.1056/NEJM198202183060706
  80. Hughes EG, Fedorkow DM, Collins JA. A quantitative overview of controlled trials in endometriosis-associated infertility. Fertil Steril 1993; 59: 963-70 https://doi.org/10.1016/S0015-0282(16)55911-1
  81. Counsellor VS. Endometriosis. A clinical and surgical review. Am J Obstet Gynecol 1938; 36: 877 https://doi.org/10.1016/S0002-9378(38)90579-4
  82. Verkauf Bs. The incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc 1987; 74: 671-5
  83. Schenken RS, Asch RH, Williams RF, Hodgen GD. Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles luteal phase defects, pelvic adhesions and spoteneous abortions. Fertil Steril 1984; 41: 122-30 https://doi.org/10.1016/S0015-0282(16)47552-7
  84. Suginami H, Yano K. An ovum capture inhibitor (OCI) in endometriosis peritoneal fluid: an OCI-related membrane responsible for fimbrial failure of ovum capture. Feril Steril 1988; 50: 648-53 https://doi.org/10.1016/S0015-0282(16)60200-5
  85. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1-10 https://doi.org/10.1016/S0015-0282(00)01630-7
  86. Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W, et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994; 79: 643-9 https://doi.org/10.1210/jc.79.2.643
  87. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for diseae-based implantation failure and infertility. Endocrinology 2003; 144: 2870-81 https://doi.org/10.1210/en.2003-0043
  88. Brugo-olmedo S, Chillik C, Kopelman S. Definition and causes of infertility. RBM Online 2000; 2(1): 41-53
  89. Bayer SR, Seibel MM, Saffan DS, Berger MJ, Taymor ML. Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective randomized study. J Reprod Med 1988; 33: 179-83
  90. Fedele L, Parazzini F, Radici E, Bocciolone L, Bianchi S, Bianchi C, et al. Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial. Am J Obstet Gynecol 1992; 166: 1345-50 https://doi.org/10.1016/0002-9378(92)91602-7
  91. Telimaa S. Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis. Fertil Steril 1988; 50: 872-5 https://doi.org/10.1016/S0015-0282(16)60364-3
  92. Thomas EJ, Cooke ID. Successful treatment of asymptomatic endometriosis: does it benefit infertile women Br Med J 1987; 294: 1117-9 https://doi.org/10.1136/bmj.294.6580.1117
  93. Hull ME, Moghissi KS, Magyar DF, Hayes MF. Comparison of different treatment modalities of endometriosis in infertile women. Fertil Steril 1987; 47: 40-4 https://doi.org/10.1016/S0015-0282(16)49933-4
  94. Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. NEngl J Med 1997; 337: 217-22 https://doi.org/10.1056/NEJM199707243370401
  95. Parazzini F. Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosis. Hum Reprod 1999; 14: 1332-4 https://doi.org/10.1093/humrep/14.5.1332
  96. Al-Inany HG, Crosignani PG, Vercellini P. Evidence may change with more trials: concepts to be kept in mind letters. Hum Reprod 2000; 15: 2447-8 https://doi.org/10.1093/humrep/15.11.2447
  97. Schenken RS. Modern concepts of endometriosis. Classification and its consequences for therapy. J Reprod Med 1998; 43: 269-75
  98. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999; 340: 177-83 https://doi.org/10.1056/NEJM199901213400302
  99. Deaton JL, Gibson M, Blackmer KM, Nakajima ST, Badger GJ, Brumsted JR. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990; 54: 1083-8 https://doi.org/10.1016/S0015-0282(16)54009-6
  100. Kemmann E, Ghazi D, Corsan G, Bohrer MK. Does ovulation stilulation improve fertility in women with minimal/mild endometriosis after laser laparoscopy Int J Fertil Menopausal Stud 1993; 38: 16-21
  101. Soliman S, Daya S, Collins J, Jarrell J. A randomized trial of in vitro fertilization versus conventional treatment for infertility. Fertil Steril 1993; 59: 1239-44 https://doi.org/10.1016/S0015-0282(16)55983-4
  102. Gibbons WE. Management of endometriosis in fertility patients. Fertil Steril 2004; 81: 1204-5 https://doi.org/10.1016/j.fertnstert.2003.10.031
  103. Dicker D, Goldman JA, Levy T, Feldberg D, Ashkenazi J. the impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril 1992; 57: 597-600 https://doi.org/10.1016/S0015-0282(16)54906-1
  104. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002; 78: 699-704 https://doi.org/10.1016/S0015-0282(02)03373-3
  105. Loh FH, Tan AT, Kumar J, Ng SC. Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles. Fertil Steil 1999; 72: 316-21 https://doi.org/10.1016/S0015-0282(99)00207-1
  106. Canis M, Pouly JL, Tamburro S,Mage G,Wattiez A, Bruhat MA. Ovarian response during IVF-embryo transfer cycles after laparoscopic ovariancystectomy for endometriotic cysts of >3 cm in diameter. Hum Reprod 2001; 16: 2583-6 https://doi.org/10.1093/humrep/16.12.2583
  107. Marconi G, Vilela M, Quintana R, Sueldo C. Laparoscopic ovarian cystectomy of endometriomas does not affect the ovarian response to gonadotropin stimulation. Fertil Steril 2002; 78: 876-8 https://doi.org/10.1016/S0015-0282(02)03326-5
  108. Garcia-Velasco JA, Mahutte NG, Corona J, Zuniga V, Giles J, Arici A, et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril 2004: 81: 1194-7 https://doi.org/10.1016/j.fertnstert.2003.04.006
  109. Ametrican Society for Reproductive Medicine. Revised Ametrican Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-21 https://doi.org/10.1016/S0015-0282(97)81391-X
  110. Serafini P, Batzofin J. Diagnosis of female infertility. A comprehensive approach. J Reprod Med 1989; 34: 29-40
  111. DeCherney AH. Anything you can do I can do better or differently! Fertil Steril 1987; 48: 374-6 https://doi.org/10.1016/S0015-0282(16)59401-1
  112. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic laparoscopicallyverified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992 ;19: 185-92 https://doi.org/10.1097/00007435-199207000-00001
  113. Creasy J, Clark RL, Cuttino JT, Groff T, Salpingitis isthmica nodosa: radiologic and clinical correlates. Radiology 1985; 154: 587-600
  114. Lisa J, Gioia J, Rubin I, Observations of the interstitial portion of the fallopian tube. Surg Gynecol Obstet 1954; 99: 159-69
  115. Fortier KJ, Haney AF. The pathologic spectrum of uterotubal junction obstruction. Obstet Gynecol 1985; 65: 93-8
  116. Punnonen R, Soderstrom KO, Alanen A. Isthmic tubal occlusion: etiology and histology. Acta Eur Fertil 1984; 15: 39-42
  117. Watson A, Vandekerckhove P, Lilford R, Vail A, Brosens I, Hughes E. A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result. Fertil Steril 1994; 61: 470-7 https://doi.org/10.1016/S0015-0282(16)56578-9
  118. Thurmond AS, Novy M, Rosch J. Terbutaline in diagnosis of interstitial fallopian tube obstruction. Invest Radiol 1988; 23: 209-10 https://doi.org/10.1097/00004424-198809000-00042
  119. Holz K, Becker R, Schurmann R. Ultrasound in the investigation of tubal patency. A meta-analysis of three comparative studies of Echovist-200 including 1007 women. Zentralbl Gynakol 1997; 119: 366-73
  120. Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med 2000; 19: 519-27 https://doi.org/10.7863/jum.2000.19.8.519
  121. Mol BW, Dijkman B, Wertheim P, Lijmer J, van der Veen F, Bossuyt PM. The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril 1997; 67: 1031-7 https://doi.org/10.1016/S0015-0282(97)81435-5
  122. Confino E, Tur-Kaspa I, DeCherney A, Corfman R, Coulam C, Robinson E, Haas G, Katz E, Vermesh M, Gleicher N. Transcervical balloon tuboplasty. A multicenter study. JAMA 1990; 264: 2079-82 https://doi.org/10.1001/jama.264.16.2079
  123. Kumpe DA, Zwerdlinger SC, Rothbarth LJ, Durham JD, Albrecht BH. Proximal fallopian tube occlusion: diagnosis and treatment with transcervical fallopian tube catheterization. Radiology 1990; 177: 183-7 https://doi.org/10.1148/radiology.177.1.2144651
  124. LaBerge JM, Ponec DJ, Gordon RL. Fallopian tube catheterization: modified fluoroscopic technique. Radiology 1990; 176: 283-4 https://doi.org/10.1148/radiology.176.1.2353103
  125. Martensson O, Nilsson B, Ekelund L, Johansson J, Wickman G. Selective salpingography and fluoroscopic transcervical salpingoplasty for diagnosis and treatment of proximal fallopian tube occlusions. Acta Obstet Gynecol Scand 1993; 72: 458-64 https://doi.org/10.3109/00016349309021135
  126. Diamond E. A comparison of gross and microsurgical techniques for repair of cornual occlusion in infertility: a retrospective study, 1968- 1978. Fertil Steril 1979; 32: 370-6
  127. Winston RM. Microsurgical tubocornual anastomosis for reversal of sterilisation. Lancet 1977; 1: 284-5
  128. Gomel V. Tubal reanastomosis by microsurgery. Fertil Steril 1977; 28: 59-65 https://doi.org/10.1016/S0015-0282(16)42318-6
  129. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR. Comperhensive Gynecology. 4th ed. St. Louis: Mosby; 2001
  130. Watson A, Vandekerckhove P, Liford R. Techniques for pelvic surgery in subfertility. Cochrane Database Syst Rev 2003; 3: CD000221. This meta-analysis evaluated data on surgical approaches to tubal infertility
  131. Audibert F, Hedon B, Arnal F, Humeau C, Boulot P, Bachelard B, Benos P, Laffargue F, Viala JL. Therapeutic strategies in tubal infertility with distal pathology. Hum Reprod. 1991; 6: 1439-42 https://doi.org/10.1093/oxfordjournals.humrep.a137284
  132. Lavy G, Diamond MP, DeCherney AH. Ectopic pregnancy: its relationship to tubal reconstructive surgery. Fertil Steril 1987; 47: 543-56 https://doi.org/10.1016/S0015-0282(16)59100-6
  133. Gomel V Salpingo-ovariolysis by laparoscopy in infertility. Fertil Steril 1983; 40: 607-11 https://doi.org/10.1016/S0015-0282(16)47418-2
  134. Fayez JA. An assessment of the role of operative laparoscopy in tuboplasty. Fertil Steril 1983; 39: 476-9 https://doi.org/10.1016/S0015-0282(16)46935-9
  135. Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, Philippe HJ. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999; 14: 1243-9 https://doi.org/10.1093/humrep/14.5.1243
  136. Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 1998; 70: 492-9 https://doi.org/10.1016/S0015-0282(98)00200-3
  137. Eytan O, Azem F, Gull I, Wolman I, Elad D and Jaffa AJ. The mechanism of hydrosalpix in embryo implantation, Hum Reprod 2001; 16: 2662-7 https://doi.org/10.1093/humrep/16.12.2662
  138. Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE and Lessey BA. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod 1997; 12: 1393-8 https://doi.org/10.1093/humrep/12.7.1393
  139. Strandell A, Sjorgen A, Bentin-Ley U, Thorburn J, Hamberger L and Brannstorm M. Hydrosalpinx fluid does not adversely affect the normal development of human embryos and implantation in vitro. Hum Reprod 1998; 13: 2921-5 https://doi.org/10.1093/humrep/13.10.2921
  140. Granot I, Dekel N, Segal I, Fieldust S, Shoham Z and Barash A. Is hydrosalpinx fluid cytotoxic Hum Reprod 1998; 13: 1620-4 https://doi.org/10.1093/humrep/13.6.1620
  141. Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY. The infertile patient with hydrosalpinges-IVF with or without salpingectomy. Hum Reprod 1996; 11: 2081-4 https://doi.org/10.1093/oxfordjournals.humrep.a019053
  142. Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999; 14: 2762-9 https://doi.org/10.1093/humrep/14.11.2762
  143. Hammadieh N, Afnan M, Evans J, Sharif K, Amso N, Olufowobi O. A postal survey of hydrosalpinx management prior to IVF in the United Kingdom. Hum Reprod 2004; 19: 1009-12 https://doi.org/10.1093/humrep/deh133
  144. Sagoskin AW, Lessey BA, Mottala GL, Richter KS, Chetkowski RJ, Chang AS, Levy MJ and Stillman RJ. Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinxincrease the potential for spontaneous pregnanc7. Hum Reprod 2003; 18: 2634-7 https://doi.org/10.1093/humrep/deg509
  145. Benadiva CA, Kligman I, Davis O, Rosenwaks Z. In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete Fertil Steril 1995; 64: 1051-61 https://doi.org/10.1016/S0015-0282(16)57958-8
  146. Menken J, Trussell J, Larsen U. Age and infertility. Science 1986; 233: 1389-94 https://doi.org/10.1126/science.3755843
  147. Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 1996; 11: 2217-22 https://doi.org/10.1093/oxfordjournals.humrep.a019080
  148. Angell RR. Aneuploidy in older women. Higher rates of aneuploidy in oocytes from older women. Hum Reprod 1994; 9: 1199-200 https://doi.org/10.1093/oxfordjournals.humrep.a138675
  149. Benadiva CA, Kligman I, Munne S. Aneuploidy 16 in human embryos increases significantly with maternal age. Fertil Steril 1996; 66: 248-55 https://doi.org/10.1016/S0015-0282(16)58448-9
  150. Noci I, Borri P, Chieffi O, Scarselli G, Biagiotti R, Moncini D, et al. Aging of the human endometrium: a basic morphological and immunohistochemical study. Eur J Obstet Gynecol Reprod Biol 1995; 63: 181-5 https://doi.org/10.1016/0301-2115(95)02244-9
  151. Navot D, Drews MR, Bergh PA, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994; 61: 97-101 https://doi.org/10.1016/S0015-0282(16)56459-0
  152. Hershlag A, Lesser M, Montefusco D, Lavy G, Kaplan P, Liu HC, et al. Interinstitutional variability of follicle-stimulating hormone and estradiol levels. Fertil Steril 1992; 58: 1123-6 https://doi.org/10.1016/S0015-0282(16)55555-1
  153. Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T. Prediction of response to ontrolled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 1992; 57: 819-24 https://doi.org/10.1016/S0015-0282(16)54965-6
  154. Scott RT, LeonardiMR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol 1993; 82: 539-44 https://doi.org/10.1097/00006250-199310000-00013
  155. Buyalos RP, Daneshmand S, Brzechffa PR. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril 1997; 68: 272-7 https://doi.org/10.1016/S0015-0282(97)81514-2
  156. Agarwal SK, Buyalos RP. Clomiphene citrate with intrauterine insemination: is it effective therapy in womenabove the age of 35 years. Fertil Steril 1996; 65: 759-63 https://doi.org/10.1016/S0015-0282(16)58210-7
  157. Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP. Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 1992; 58: 674-9 https://doi.org/10.1016/S0015-0282(16)55310-2
  158. Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile Hum Reprod 1996; 11: 1109-10 https://doi.org/10.1093/oxfordjournals.humrep.a019306
  159. Centers for Disease Control and prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, RESOLVE. 1999 Assisted reproductive technology success rates. Atlanta, GA: Centers for Disease Control and Prevention, 2001
  160. Ron-El R, Raziel A, Strassburger D, Schachter M, Kasterstein E, Friedler S. Outcome of assisted reproductive technology in women over the age of 41. Fertil Steril 2000; 74: 471-5 https://doi.org/10.1016/S0015-0282(00)00697-X
  161. Zhang J, Wang CW, Krey L, Liu H, Meng L, Blaszczyk A, et al. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. Fertil Steril 1999; 71: 726-31 https://doi.org/10.1016/S0015-0282(98)00549-4
  162. Hook EB.Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58: 282-5
  163. Simpson JL, Bombard A, Bennett MJ, Edmonds DK, eds. Chromosomal abnormalities in spontaneous abortion: frequency, pathology and genetic, counseling. In: spontaneous and recurrent abortion. Oxford Blackwell Scientific; 1987: 51-76
  164. ACOG Committee Opinion. Advanced paternal age: risks to the fetus. Number 189, October 1998. Committee on Genetics. American College of Obstetricians and Gynecologists
  165. Thompson MW, McInnes RR, Willard HF, eds. Patterns of singlegene inheritance. In: Thompson and Thompson genetics in medicine. 5th ed. Philadelphia, PA: WB Saunders 2001: 53-95
  166. Warburton D, Strobino B, Bennett MJ, Edmonds DK, eds. Recurrent spontaneous abortions. In: Spontaneous and recurrent abortion. Oxford Blackwell Scientific 1987: 193-213
  167. Layman LC, Reindollar RH. The genetics of hypogonadism. Infertil Reprod Med Clin N Am 1994; 5: 53-68
  168. Jones KL. In: Smith's recognizable patterns of human malformation. 5th ed. Philadelphia, PA: WB Saunders Company 1998: 482-3
  169. Layman LC, Lobo RA, ed. Familial ovarian failure: In: perimenopause. New York, NY: Springer-Verlag 1997: 46-77
  170. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase-deficient onclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72: 915-25 https://doi.org/10.1016/S0015-0282(99)00383-0
  171. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535-43 https://doi.org/10.1093/humupd/7.6.535
  172. Agarwal A, Ranganathan P, Kattal N, et al. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril 2004; 81: 342-8 https://doi.org/10.1016/j.fertnstert.2003.07.021
  173. Vigersky R, Andersen A, Thompson R, et al. Hypothalamic dysfunction in secondary amenorrhea associated with simple weight loss. N Engl J Med 1977; 297: 1141-5 https://doi.org/10.1056/NEJM197711242972103
  174. Schenker J, Meirow D, Schenker E. Stress and human reproduction. Eur J Obstet, Gynecol, Reprod Bio 1992; 45: 1-8
  175. Critchley H, Bath L, Wallace W. Radiation damage to the uterusreview of the effects of treatment of childhood cancer. Hum Fertil (Cambridge) 2002; 5: 61-6 https://doi.org/10.1080/1464727022000198942
  176. Franchi-Rezgui P, Rousselot P, Espie M, et al. Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 2003; 4: 116-20 https://doi.org/10.1038/sj.thj.6200248
  177. Chen WY, Yang JG, Huang SH, et al. Effects of cyclophosphamide on maturation and subsequent fertilizing capacity of pig oocytes in vitro. 1998 Chinese J Physiol 1998; 41: 75-83
  178. Ginsburg E, Yanushpolsky E, Jackson K. In vitro fertilization for cancer patients and survivors. Fertil Steril 2001; 75: 705-10 https://doi.org/10.1016/S0015-0282(00)01802-1
  179. Lockwood G. Politics, ethics and economics: oocyte cryopreservation in the UK. Reprod BioMed Online 2003; 6: 151-3 https://doi.org/10.1016/S1472-6483(10)61701-4
  180. Gook D, Osborn S, Bourne H, et al. Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 1994; 9: 684-91 https://doi.org/10.1093/oxfordjournals.humrep.a138572
  181. Porcu 2004 Larsen E, Loft A, Holm K, et al. Oocyte donation in women cured of cancer with bone marrow transplantation including total body irradiation in adolescence. Hum Reprod 2000; 15: 1505-8 https://doi.org/10.1093/humrep/15.7.1505
  182. Larsen E, Loft A, HolmK, et al. Oocyte donation inwomen cured of cancer with bone marrow transplantation including total body irradiation in adolescence. Hum Reprod 2000; 15: 1505-8 https://doi.org/10.1093/humrep/15.7.1505
  183. Oktay K. Successful human ovarian autotransplantation to upper arm Cancer 2005 Mar. 22
  184. Kim S, Radford J, Harris M, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 2001; 16: 2056-60 https://doi.org/10.1093/humrep/16.10.2056
  185. Donnez J, Dolmans M, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1-6 https://doi.org/10.1016/S0140-6736(04)16603-8
  186. Radford J, Clark S, Crowther D, et al. Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and nonHodgkin's lymphoma. Br J Cancer 1994; 69: 379-81 https://doi.org/10.1038/bjc.1994.69
  187. Meistrich ML, Wilson G, Mathur K, et al. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease. J Clinic Oncol 1997; 15: 3488-95 https://doi.org/10.1200/JCO.1997.15.12.3488
  188. Williams R, Littell R, Mendenhall N. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 1999; 86: 2139-42
  189. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and B as markers. Mol Cel Endo 2002; 187: 93-105 https://doi.org/10.1016/S0303-7207(01)00712-2
  190. Critchley H, Bath L, Wallace W. Radiation damage to the uterusreview of the effects of treatment of childhood cancer. Hum Fertil (Cambridge) 2002; 5: 61-6 https://doi.org/10.1080/1464727022000198942
  191. Morita Y, Perez G, Paris F, et al Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1- phosphate therapy. Nature Edicine 2000; 6: 1109-14 https://doi.org/10.1038/80442